高级检索

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

人乳头瘤病毒相关头颈癌流行病学研究进展

贾鑫华 苏征 李煜霏 吴婷 乔友林

贾鑫华, 苏征, 李煜霏, 吴婷, 乔友林. 人乳头瘤病毒相关头颈癌流行病学研究进展[J]. 中国公共卫生, 2022, 38(11): 1489-1493. doi: 10.11847/zgggws1136127
引用本文: 贾鑫华, 苏征, 李煜霏, 吴婷, 乔友林. 人乳头瘤病毒相关头颈癌流行病学研究进展[J]. 中国公共卫生, 2022, 38(11): 1489-1493. doi: 10.11847/zgggws1136127
JIA Xin-hua, SU Zheng, LI Yu-fei, . Advances in epidemiologic researches on human papillomavirus-associated head and neck cancer[J]. Chinese Journal of Public Health, 2022, 38(11): 1489-1493. doi: 10.11847/zgggws1136127
Citation: JIA Xin-hua, SU Zheng, LI Yu-fei, . Advances in epidemiologic researches on human papillomavirus-associated head and neck cancer[J]. Chinese Journal of Public Health, 2022, 38(11): 1489-1493. doi: 10.11847/zgggws1136127

人乳头瘤病毒相关头颈癌流行病学研究进展

doi: 10.11847/zgggws1136127
基金项目: 中国医学科学院医学与健康科技创新工程 服务“一带一路”战略先导科研专项(2017 – I2M – B&R – 03)
详细信息
    作者简介:

    贾鑫华(1996 – ),男,甘肃天水人,硕士在读,研究方向:肿瘤流行病学

    通讯作者:

    乔友林,E-mail:qiaoy@cicams.ac.cn

  • 中图分类号: R 73

Advances in epidemiologic researches on human papillomavirus-associated head and neck cancer

  • 摘要: 头颈癌(HNC)的病因主要是烟草和酒精的暴露,在戒烟行动的号召下,吸烟相关的HNC发病率下降,人乳头瘤病毒(HPV)感染导致HNC的病例逐渐增多,尤其是发达国家,其中在美国HPV相关HNC超过宫颈癌成为HPV相关的第一大肿瘤。此外,随HPV疫苗的陆续上市,宫颈癌的研究逐渐进入后疫苗时代,HPV其他相关肿瘤,尤其是HNC成为下一研究的热点。
  • [1] Tumban E. A current update on human papillomavirus-associated head and neck cancers[J]. Viruses, 2019, 11(10): 922. doi: 10.3390/v11100922
    [2] Chow LQM. Head and neck cancer[J]. New England Journal of Medicine, 2020, 382(1): 60 – 72. doi: 10.1056/NEJMra1715715
    [3] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:A Cancer Journal for Clinicians, 2021, 71(3): 209 – 249. doi: 10.3322/caac.21660
    [4] Zhang SW, Sun KX, Zheng RS, et al. Cancer incidence and mortality in China, 2015[J]. Journal of the National Cancer Center, 2021, 1(1): 2 – 11. doi: 10.1016/j.jncc.2020.12.001
    [5] Adegboyega PA, Boromound N, Freeman DH. Diagnostic utility of cell cycle and apoptosis regulatory proteins in verrucous squamous carcinoma[J]. Applied Immunohistochemistry and Molecular Morphology, 2005, 13(2): 171 – 177. doi: 10.1097/01.pai.0000132190.39351.9b
    [6] Fakhry C, Westra WH, Li SG, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial[J]. JNCI:Journal of the National Cancer Institute, 2008, 100(4): 261 – 269. doi: 10.1093/jnci/djn011
    [7] Szentirmay Z, Pólus K, Tamás L, et al. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations[J]. Cancer and Metastasis Reviews, 2005, 24(1): 19 – 34. doi: 10.1007/s10555-005-5045-3
    [8] Chang CP, Siwakoti B, Sapkota A, et al. Tobacco smoking, chewing habits, alcohol drinking and the risk of head and neck cancer in Nepal[J]. International Journal of Cancer, 2020, 147(3): 866 – 875. doi: 10.1002/ijc.32823
    [9] Beynon RA, Lang S, Schimansky S, et al. Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: results from head and neck 5000, a prospective observational cohort of people with head and neck cancer[J]. International Journal of Cancer, 2018, 143(5): 1114 – 1127. doi: 10.1002/ijc.31416
    [10] Chen SY, Massa S, Mazul AL, et al. The association of smoking and outcomes in HPV-positive oropharyngeal cancer: a syste-matic review[J]. American Journal of Otolaryngology, 2020, 41(5): 102592. doi: 10.1016/j.amjoto.2020.102592
    [11] Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium[J]. JNCI:Journal of the National Cancer Institute, 2007, 99(10): 777 – 789. doi: 10.1093/jnci/djk179
    [12] Wyss A, Hashibe M, Chuang SC, et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the international head and neck cancer epidemiology consortium[J]. American Journal of Epidemiology, 2013, 178(5): 679 – 690. doi: 10.1093/aje/kwt029
    [13] Lewin F, Norell SE, Johansson H, et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck[J]. Cancer, 1998, 82(7): 1367 – 1375. doi: 10.1002/(SICI)1097-0142(19980401)82:7<1367::AID-CNCR21>3.0.CO;2-3
    [14] Andre K, Schraub S, Mercier M, et al. Role of alcohol and tobacco in the aetiology of head and neck cancer: a case-control study in the Doubs region of France[J]. European Journal of Cancer Part B:Oral Oncology, 1995, 31(5): 301 – 309. doi: 10.1016/0964-1955(95)00041-0
    [15] Simard EP, Torre LA, Jemal A. International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site[J]. Oral Oncology, 2014, 50(5): 387 – 403. doi: 10.1016/j.oraloncology.2014.01.016
    [16] De Stefani E, Boffetta P, Oreggia F, et al. Hard liquor drinking is associated with higher risk of cancer of the oral cavity and pharynx than wine drinking. A case-control study in Uruguay[J]. Oral Oncology, 1998, 34(2): 99 – 104. doi: 10.1016/S1368-8375(97)00062-6
    [17] Raghupathy R, Hui EP, Chan ATC. Epstein-Barr virus as a paradigm in nasopharyngeal cancer: from lab to clinic[J]. American Society of Clinical Oncology Educational Book, 2014, 34(34): 149 – 153.
    [18] Mosmann JP, Talavera AD, Criscuolo MI, et al. Sexually transmitted infections in oral cavity lesions: human papillomavirus, Chlamydia trachomatis, and herpes simplex virus[J]. Journal of Oral Microbiology, 2019, 11(1): 1632129. doi: 10.1080/20002297.2019.1632129
    [19] Mahale P, Sturgis EM, Tweardy DJ, et al. Association between hepatitis C virus and head and neck cancers[J]. JNCI:Journal of the National Cancer Institute, 2016, 108(8): djw035. doi: 10.1093/jnci/djw035
    [20] D′Souza G, Carey TE, William Jr WN, et al. Epidemiology of head and neck squamous cell cancer among HIV-infected patients[J]. Journal of Acquired Immune Deficiency Syndromes, 2014, 65(5): 603 – 610. doi: 10.1097/QAI.0000000000000083
    [21] Nayyar SS, Thiagarajan S, Malik A, et al. Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients – prognosis and its predictors[J]. Journal of Cancer Research and Therapeutics, 2020, 16(3): 619 – 623. doi: 10.4103/jcrt.JCRT_166_19
    [22] Haase K, Piwonski I, Stromberger C, et al. Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients[J]. European Archives of Oto-Rhino-Laryngology, 2021, 278(10): 3941 – 3953. doi: 10.1007/s00405-020-06573-9
    [23] Beachler DC, D'Souza G. Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals[J]. Current Opinion in Oncology, 2013, 25(5): 503 – 510. doi: 10.1097/CCO.0b013e32836242b4
    [24] Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillo-mavirus infection in adults is associated with sexual behavior and HIV serostatus[J]. The Journal of Infectious Diseases, 2004, 189(4): 686 – 698. doi: 10.1086/381504
    [25] Castellsagué X, Mena M, Alemany L. Epidemiology of HPV-positive tumors in Europe and in the world[M]//Golusiński W, Leemans C R, Dietz A. HPV Infection in Head and Neck Cancer. Cham: Springer, 2017: 27 – 35.
    [26] Sabatini ME, Chiocca S. Human papillomavirus as a driver of head and neck cancers[J]. British Journal of Cancer, 2020, 122(3): 306 – 314. doi: 10.1038/s41416-019-0602-7
    [27] Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer[J]. Cancer Cell, 2004, 5(4): 311 – 316. doi: 10.1016/S1535-6108(04)00090-X
    [28] House R, Majumder M, Janakiraman H, et al. Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer[J]. PLoS One, 2018, 13(10): e0205077. doi: 10.1371/journal.pone.0205077
    [29] Bosetti C, McLaughlin JK, Tarone RE, et al. Formaldehyde and cancer risk: a quantitative review of cohort studies through 2006[J]. Annals of Oncology, 2008, 19(1): 29 – 43. doi: 10.1093/annonc/mdm202
    [30] Carton M, Barul C, Menvielle G, et al. Occupational exposure to solvents and risk of head and neck cancer in women: a population-based case-control study in France[J]. BMJ Open, 2017, 7(1): e012833. doi: 10.1136/bmjopen-2016-012833
    [31] Da Silva Leonel ACL, Bonan RF, Pinto MBR, et al. The pesticides use and the risk for head and neck cancer: a review of case-control studies[J]. Medicina Oral, Patología Oral y Cirugia Bucal, 2021, 26(1): e56 – e63.
    [32] Guha N, Warnakulasuriya S, Vlaanderen J, et al. Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control[J]. International Journal of Cancer, 2014, 135(6): 1433 – 1443. doi: 10.1002/ijc.28643
    [33] Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA:A Cancer Journal for Clinicians, 2005, 55(2): 74 – 108. doi: 10.3322/canjclin.55.2.74
    [34] Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 Apr 5. doi:10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.
    [35] Desantis CE, Miller KD, Sauer AG, et al. Cancer statistics for African Americans, 2019[J]. CA:A Cancer Journal for Clinicians, 2019, 69(3): 211 – 233. doi: 10.3322/caac.21555
    [36] Desantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013[J]. CA:A Cancer Journal for Clinicians, 2013, 63(3): 151 – 166. doi: 10.3322/caac.21173
    [37] Louie KS, Mehanna H, Sasieni P. Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025[J]. Oral Oncology, 2015, 51(4): 341 – 348. doi: 10.1016/j.oraloncology.2015.01.002
    [38] Patterson RH, Fischman VG, Wasserman I, et al. Global burden of head and neck cancer: economic consequences, health, and the role of surgery[J]. Otolaryngology-Head and Neck Surgery, 2020, 162(3): 296 – 303. doi: 10.1177/0194599819897265
    [39] Wood ZC, Bain CJ, Smith DD, et al. Oral human papillomavirus infection incidence and clearance: a systematic review of the literature[J]. Journal of General Virology, 2017, 98(4): 519 – 526. doi: 10.1099/jgv.0.000727
    [40] Gillison ML, Chaturvedi AK, Anderson WF, et al. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma[J]. Journal of Clinical Oncology, 2015, 33(29): 3235 – 3242. doi: 10.1200/JCO.2015.61.6995
    [41] Tagliabue M, Mena M, Maffini F, et al. Role of human papillomavirus infection in head and neck cancer in Italy: the HPV-AHEAD study[J]. Cancers, 2020, 12(12): 3567. doi: 10.3390/cancers12123567
    [42] Eytan DF, Blackford AL, Eisele DW, et al. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States[J]. Cancer, 2019, 125(2): 249 – 260. doi: 10.1002/cncr.31800
    [43] Young D, Xiao CC, Murphy B, et al. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV)[J]. Oral Oncology, 2015, 51(8): 727 – 730. doi: 10.1016/j.oraloncology.2015.03.015
    [44] 何保昌, 徐钦, 何斐, 等. HPV与头颈部鳞状细胞癌预后关系Meta分析[J]. 中国公共卫生, 2013, 29(3): 446 – 448. doi: 10.11847/zgggws2013-29-03-47
    [45] Maxwell JH, Grandis JR, Ferris RL. HPV-associated head and neck cancer: unique features of epidemiology and clinical management[J]. Annual Review of Medicine, 2016, 67: 91 – 101. doi: 10.1146/annurev-med-051914-021907
    [46] Galvis MM, Borges GA, De Oliveira TB, et al. Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: a systematic review and meta-analysis[J]. Critical Reviews in Oncology/Hematology, 2020, 150: 102966. doi: 10.1016/j.critrevonc.2020.102966
    [47] Tian SB, Switchenko JM, Jhaveri J, et al. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: a propensity-scored analysis of the National Cancer Data Base[J]. Cancer, 2019, 125(16): 2782 – 2793.
    [48] De Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type[J]. International Journal of Cancer, 2017, 141(4): 664 – 670. doi: 10.1002/ijc.30716
    [49] Aupérin A. Epidemiology of head and neck cancers: an update[J]. Current Opinion in Oncology, 2020, 32(3): 178 – 186. doi: 10.1097/CCO.0000000000000629
    [50] Elwood JM, Youlden DR, Chelimo C, et al. Comparison of oropharyngeal and oral cavity squamous cell cancer incidence and trends in New Zealand and Queensland, Australia[J]. Cancer Epidemiology, 2014, 38(1): 16 – 21. doi: 10.1016/j.canep.2013.12.004
    [51] Forte T, Niu J, Lockwood GA, et al. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992 – 2009[J]. Cancer Causes and Control, 2012, 23(8): 1343 – 1348. doi: 10.1007/s10552-012-0013-z
    [52] Hwang TZ, Hsiao JR, Tsai CR, et al. Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995 – 2009[J]. International Journal of Cancer, 2015, 137(2): 395 – 408. doi: 10.1002/ijc.29330
    [53] Cole L, Polfus L, Peters ES. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U. S., 1995 – 2005[J]. PLoS One, 2012, 7(3): e32657. doi: 10.1371/journal.pone.0032657
    [54] Blomberg M, Nielsen A, Munk C, et al. Trends in head and neck cancer incidence in Denmark, 1978 – 2007: focus on human papillomavirus associated sites[J]. International Journal of Cancer, 2011, 129(3): 733 – 741. doi: 10.1002/ijc.25699
    [55] Chan MH, Wang F, Mang WK, et al. Sex differences in time trends on incidence rates of oropharyngeal and oral cavity cancers in Hong Kong[J]. Annals of Otology, Rhinology and Laryngology, 2018, 127(12): 895 – 902. doi: 10.1177/0003489418802287
    [56] Licitra L, Zigon G, Gatta G, et al. Human papillomavirus in HNSCC: a European epidemiologic perspective[J]. Hematology/Oncology Clinics of North America, 2008, 22(6): 1143 – 1153. doi: 10.1016/j.hoc.2008.10.002
    [57] Du M, Nair R, Jamieson L, et al. Incidence trends of lip, oral cavity, and pharyngeal cancers: global burden of disease 1990 – 2017[J]. Journal of Dental Research, 2020, 99(2): 143 – 151. doi: 10.1177/0022034519894963
    [58] Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study[J]. JAMA Oncology, 2019, 5(12): 1749 – 1768. doi: 10.1001/jamaoncol.2019.2996
    [59] Dos Santos Menezes F, Fernandes GA, Antunes JLF, et al. Global incidence trends in head and neck cancer for HPV-related and-unrelated subsites: a systematic review of population-based studies[J]. Oral Oncology, 2021, 115: 105177. doi: 10.1016/j.oraloncology.2020.105177
    [60] Timbang MR, Sim MW, Bewley AF, et al. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection[J]. Human Vaccines and Immunotherapeutics, 2019, 15(7/8): 1920 – 1928.
    [61] Borget I, Abramowitz L, Mathevet P. Economic burden of HPV-related cancers in France[J]. Vaccine, 2011, 29(32): 5245 – 5249. doi: 10.1016/j.vaccine.2011.05.018
    [62] 张继红, 腾国伟, 斗智, 等. 九价人乳头瘤病毒疫苗接种后保护效果、免疫原性及安全性meta分析[J]. 中国公共卫生, 2019, 35(4): 491 – 496. doi: 10.11847/zgggws1121035
    [63] Pinto LA, Kemp TJ, Torres BN, et al. Quadrivalent human papillomavirus (HPV) vaccine induces HPV-specific antibodies in the oral cavity: results from the mid-adult male vaccine trial[J]. The Journal of Infectious Diseases, 2016, 214(8): 1276 – 1283. doi: 10.1093/infdis/jiw359
    [64] Parker KH, Kemp TJ, Pan YJ, et al. Evaluation of HPV-16 and HPV-18 specific antibody measurements in saliva collected in oral rinses and merocel® sponges[J]. Vaccine, 2018, 36(19): 2705 – 2711. doi: 10.1016/j.vaccine.2018.03.034
    [65] Mehanna H, Bryant TS, Babrah J, et al. Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV-16 prevalence in the united kingdom: a cross-sectional study[J]. Clinical Infectious Diseases, 2019, 69(8): 1296 – 1302. doi: 10.1093/cid/ciy1081
    [66] Herrero R, Quint W, Hildesheim A, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in costa Rica[J]. PLoS One, 2013, 8(7): e68329. doi: 10.1371/journal.pone.0068329
    [67] Lehtinen M, Apter D, Eriksson T, et al. Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females – results from a community-randomized trial[J]. International Journal of Cancer, 2020, 147(1): 170 – 174. doi: 10.1002/ijc.32791
    [68] Kreimer AR, Chaturvedi AK, Alemany L, et al. Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI[J]. Oral Oncology, 2020, 108: 104736. doi: 10.1016/j.oraloncology.2020.104736
    [69] Hashim D, Genden E, Posner M, et al. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden[J]. Annals of Oncology, 2019, 30(5): 744 – 756. doi: 10.1093/annonc/mdz084
  • 加载中
计量
  • 文章访问数:  65
  • HTML全文浏览量:  13
  • PDF下载量:  14
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-07-06
  • 网络出版日期:  2022-09-13
  • 刊出日期:  2022-11-30

目录

    /

    返回文章
    返回